EISAI-E2007-J000-335

Study Sponsor: Eisai

Study Title

A Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures

Medicine or Vaccine (generic name)

perampanel

Sponsor Identification Number

E2007-J000-335

Trial Registry Identification Number(#'s)

NCT01618695

Medical Condition

Partial-onset Seizures

Phase

Phase 3

Link to study details on the Eisai Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT01618695

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Additional information about the data and documents available for this study

No restrictions.

Date Added to this Site

November 2018